123 related articles for article (PubMed ID: 2837955)
1. Novel molecules that antagonize leukotriene B4 binding to neutrophils.
Lin AH; Morris J; Wishka DG; Gorman RR
Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955
[TBL] [Abstract][Full Text] [Related]
2. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.
Gapinski DM; Mallett BE; Froelich LL; Jackson WT
J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648
[TBL] [Abstract][Full Text] [Related]
3. omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists.
Labaudinière R; Hendel W; Terlain B; Cavy F; Marquis O; Dereu N
J Med Chem; 1992 Nov; 35(23):4306-14. PubMed ID: 1333011
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a series of substituted-phenylpropionic acids as a novel class of leukotriene B4 antagonists.
Konno M; Sakuyama S; Nakae T; Hamanaka N; Miyamoto T; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():411-4. PubMed ID: 1847779
[No Abstract] [Full Text] [Related]
6. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777
[No Abstract] [Full Text] [Related]
7. Synthesis of structural analogues of leukotriene B4 and their receptor binding activity.
Konno M; Nakae T; Sakuyama S; Nishizaki M; Odagaki Y; Nakai H; Hamanaka N
Bioorg Med Chem; 1997 Aug; 5(8):1621-47. PubMed ID: 9313867
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS
J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
[TBL] [Abstract][Full Text] [Related]
10. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4.
Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ
J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
Jackson RH; Morrissey MM; Sills MA; Jarvis MF
J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
[TBL] [Abstract][Full Text] [Related]
12. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus.
Gapinski DM; Mallett BE; Froelich LL; Jackson WT
J Med Chem; 1990 Oct; 33(10):2798-807. PubMed ID: 2170647
[TBL] [Abstract][Full Text] [Related]
13. Selective modulation by guanine nucleotides of the high affinity subset of plasma membrane receptors for leukotriene B4 on human polymorphonuclear leukocytes.
Sherman JW; Goetzl EJ; Koo CH
J Immunol; 1988 Jun; 140(11):3900-4. PubMed ID: 2836504
[TBL] [Abstract][Full Text] [Related]
14. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
[TBL] [Abstract][Full Text] [Related]
15. Structure/activity relationship of leukotriene B4 and its structural analogues in chemotactic, lysosomal-enzyme release and receptor-binding assays.
Soyombo O; Spur BW; Soh C; Lee TH
Eur J Biochem; 1993 Nov; 218(1):59-66. PubMed ID: 8243477
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the spatial arrangement of the two acid-binding sites on the human neutrophil LTB4 receptor.
Chaney MO; Froelich LL; Gapinski DM; Mallett BE; Jackson WT
Receptor; 1992; 2(3):169-79. PubMed ID: 1335328
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LTB4 binding to human neutrophils by nordihydroguaiaretic acid.
Maloff BL; Fefer D; Cooke GM; Ackerman NR
Agents Actions; 1987 Aug; 21(3-4):358-60. PubMed ID: 2825484
[TBL] [Abstract][Full Text] [Related]
18. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
Powell WS; Rokach J; Khanapure SP; Manna S; Hashefi M; Gravel S; Macleod RJ; Falck JR; Bhatt RK
J Pharmacol Exp Ther; 1996 Feb; 276(2):728-36. PubMed ID: 8632343
[TBL] [Abstract][Full Text] [Related]
19. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of the leukotriene B4 receptor by partial agonists.
Kiel D; Zipkin RE; Feinmark SJ
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():403-6. PubMed ID: 1847776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
